Urticaria type drug eruption that occurred three days after completion of oral administration of minocycline hydrochloric acid

Ryutaro Ichikawa, Miki Ichikawa, Masutaka Furue

Research output: Contribution to journalArticle

Abstract

On the third day after completion of 15-day oral administration of minocycline hydrochloric acid (Minomycin®), edematous erythema over the entire body accompanying breathing difficulty developed in a 39-year-old woman. She was admitted to hospital and treatment with prednisolone (Prednine®) at 40 mg/day was started. A diagnosis of urticaria type drug eruption caused by minocycline hydrochloric acid was made on the basis of results of pathological histology and reoral tests. To the best of our knowledge, there has been no report on urticaria type drug eruption 3 days after oral administration of minocycline hydrochloric acid. It was thought that characteristic pharmacokinetics of minocycline hydrochloric acid were involved.

Original languageEnglish
Pages (from-to)428-433
Number of pages6
JournalSkin Research
Volume7
Issue number4
Publication statusPublished - Aug 2008

Fingerprint

Drug Eruptions
Minocycline
Hydrochloric Acid
Urticaria
Oral Administration
Erythema
Prednisolone
Histology
Respiration
Pharmacokinetics

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Infectious Diseases

Cite this

Urticaria type drug eruption that occurred three days after completion of oral administration of minocycline hydrochloric acid. / Ichikawa, Ryutaro; Ichikawa, Miki; Furue, Masutaka.

In: Skin Research, Vol. 7, No. 4, 08.2008, p. 428-433.

Research output: Contribution to journalArticle

@article{2ef58f2aecca4bb5b3bb7c0247c0c43c,
title = "Urticaria type drug eruption that occurred three days after completion of oral administration of minocycline hydrochloric acid",
abstract = "On the third day after completion of 15-day oral administration of minocycline hydrochloric acid (Minomycin{\circledR}), edematous erythema over the entire body accompanying breathing difficulty developed in a 39-year-old woman. She was admitted to hospital and treatment with prednisolone (Prednine{\circledR}) at 40 mg/day was started. A diagnosis of urticaria type drug eruption caused by minocycline hydrochloric acid was made on the basis of results of pathological histology and reoral tests. To the best of our knowledge, there has been no report on urticaria type drug eruption 3 days after oral administration of minocycline hydrochloric acid. It was thought that characteristic pharmacokinetics of minocycline hydrochloric acid were involved.",
author = "Ryutaro Ichikawa and Miki Ichikawa and Masutaka Furue",
year = "2008",
month = "8",
language = "English",
volume = "7",
pages = "428--433",
journal = "Skin Research",
issn = "0018-1390",
publisher = "Osaka University",
number = "4",

}

TY - JOUR

T1 - Urticaria type drug eruption that occurred three days after completion of oral administration of minocycline hydrochloric acid

AU - Ichikawa, Ryutaro

AU - Ichikawa, Miki

AU - Furue, Masutaka

PY - 2008/8

Y1 - 2008/8

N2 - On the third day after completion of 15-day oral administration of minocycline hydrochloric acid (Minomycin®), edematous erythema over the entire body accompanying breathing difficulty developed in a 39-year-old woman. She was admitted to hospital and treatment with prednisolone (Prednine®) at 40 mg/day was started. A diagnosis of urticaria type drug eruption caused by minocycline hydrochloric acid was made on the basis of results of pathological histology and reoral tests. To the best of our knowledge, there has been no report on urticaria type drug eruption 3 days after oral administration of minocycline hydrochloric acid. It was thought that characteristic pharmacokinetics of minocycline hydrochloric acid were involved.

AB - On the third day after completion of 15-day oral administration of minocycline hydrochloric acid (Minomycin®), edematous erythema over the entire body accompanying breathing difficulty developed in a 39-year-old woman. She was admitted to hospital and treatment with prednisolone (Prednine®) at 40 mg/day was started. A diagnosis of urticaria type drug eruption caused by minocycline hydrochloric acid was made on the basis of results of pathological histology and reoral tests. To the best of our knowledge, there has been no report on urticaria type drug eruption 3 days after oral administration of minocycline hydrochloric acid. It was thought that characteristic pharmacokinetics of minocycline hydrochloric acid were involved.

UR - http://www.scopus.com/inward/record.url?scp=55549140561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55549140561&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 428

EP - 433

JO - Skin Research

JF - Skin Research

SN - 0018-1390

IS - 4

ER -